New TB drug cocktail tested for faster action
NCT ID NCT05382312
Summary
This study tested a new tuberculosis drug, GSK3036656, in different two-drug combinations for 14 days. It involved 127 adults with newly diagnosed, drug-sensitive lung TB. The main goal was to see how quickly these combinations could kill the TB bacteria in sputum and to check their safety, before patients switched back to standard long-term treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Bellville, 7530, South Africa
Conditions
Explore the condition pages connected to this study.